Chi Zhu

Chi Zhu

Auto-generated profile, based on publicly available information

Chi Zhu

Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200123, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2016 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
Chenghui LiuChenghui Liu
Chenghui Liu
XBXian-Le Bu
Xian-Le Bu
JWJun Wang
Jun Wang
TZTao Zhang
Tao Zhang
YXYang Xiang
Yang Xiang
YWYanjiang Wang
Yanjiang Wang
These authors contributed equally to this work. Background: Capsaicin-rich diets are common worldwide. Capsaicin has been shown to have favorable effects on various diseases including atherosclerosis, cardiovascular diseases, stroke, obesity, hyperte

17 February 2022 in Practical Laboratory Medicine
Verified
Journal Article
Open access
CZChi Zhu
Chi Zhu
LSLili Sun
Lili Sun
HLHaowei Li
Haowei Li
ZDZhenghua Dong
Zhenghua Dong
SYSiyuan Yu
Siyuan Yu
WWWenjuan Wu
Wenjuan Wu
Due to the use of different detection reagents and methods, coagulation analyzers can produce different results. Therefore, detection instruments, reagents and methods are important factors affecting the results of coagulation test. Therefore, this paper aims to establish reference intervals applicable to our laboratory for the Roche Cobas t 711 for routine coagulation assays. Methods:We completed a preliminary evaluation of the analytical performance of the cobas t 711 before any experiment. Healthy volunteer recruitment and ostensibly healthy patients via physical examination were performed to collect individual reference samples. Data were grouped and compared according to age, and the Z test was used to determine whether there was a statistically significant difference between the mean values after grouping. The self-established PT, APTT and TT reference intervals were 8.4–10.2s, 26.8–42.3s and 14.5–17.1s, respectively. The reference ranges of FIB, AT and DD for people aged 50 years or below were 1.85–3.78 (g/l), 83.9–113.2 (%) and 0–0.45 (mg/l), respectively, and those for people older than 50 years were 2.22–3.86 (g/l), 76.0–112.0 (%) and 0–0.52 (mg/l), respectively. The self-built reference intervals for the Roche t 711 were basically consistent with those in the instructions, except the APTT ranges were slightly wider. Laboratories should establish applicable reference intervals according to their own conditions to provide guidance for the diagnosis, monitoring and prognosis of clinically related diseases.